Health Condition 1: N185- Chronic kidney disease, stage 5 Health Condition 2: N185- Chronic kidney disease, stage 5 Health Condition 3: N185- Chronic kidney disease, stage 5
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients aged 18 years and above of both sexes. 2. Patients on hemodialysis for more than 6 months. 3. Patients willing to provide consent.
Exclusion criteria
Exclusion criteria: 1. Patients with active malignancy. 2. Patients with severe hepatic impairment. 3. Patients on peritoneal dialysis and hemodiafiltration. 4. Familial hypertriglyceridemia. 5. Acute pancreatitis. 6. Patients on Anti-Hyperlipidemic and its combination with other medications.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Routine laboratory parameters: Heamoglobin, Urea, eGFR, Creatinine, Potassium, calcium, phosphorous, RBS, Albumin, Alkaline phosphatase.Presence and absence of diabetes Lipid Profile: Lipid profiles (HDL, LDL, TG, TC).Gender Modified Charlson Comorbidity Index scoreFrequency of HD Risk Factors: Hypertension BMIAnemia eGFRUremia Social Habits: Smoking, Alcohol and othersComorbid conditions: CHD, stroke, Cirrhosis, Peripheral vascular disease, Hypertension, Diabetes Duration on RRT Timepoint: At baseline visit | — |
Secondary
| Measure | Time frame |
|---|---|
| Risk Factors: Hypertension BMI Anemia eGFR Uremia Social Habits: Smoking, Alcohol and others Comorbid conditions: CHD, stroke, Cirrhosis, Peripheral vascular disease, Hypertension, Diabetes Frequency of HD Duration on RRT Timepoint: At baseline visit | — |
Countries
India
Contacts
NGSM Institute of Pharamceutical Sciences,Deralakatte,Mangaluru